Kari Wolatz, MD

Dr Wolatz is a third-year psychiatry resident at Creighton University.

Articles by Kari Wolatz, MD

Safety and Efficacy of Intranasal Esketamine for Major Depressive Disorder and Treatment-Resistant Depression

ByNick Ratzloff, DO,Ayse K. Coskun, MD,Kari Wolatz, MD,Albert Dickan, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

June 15th 2026

Meta-analysis finds intranasal esketamine boosts remission in MDD and TRD fast, but side effects and short trials leave long-term questions.

Cognitive Effects of Antidepressant Pharmacotherapy in Late-Life Depression

ByLior Hilsenrath, MD,Kari Wolatz, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

August 15th 2025

Antidepressant treatment for late-life depression enhances cognitive functions like memory and learning, linking symptom relief to cognitive improvement.

Kari Wolatz, MD

Articles by Kari Wolatz, MD

Safety and Efficacy of Intranasal Esketamine for Major Depressive Disorder and Treatment-Resistant Depression

Cognitive Effects of Antidepressant Pharmacotherapy in Late-Life Depression

Latest Updated Articles

Trending on Psychiatric Times

The Top 10 Misleading Claims About Antidepressants

What Does July 4th Mean for Patients? A Psychiatric Perspective on Holiday Vulnerability

Positive Phase 3 Data for Centanafadine to Treat Comorbid ADHD and Anxiety

Burnout, Moral Injury, and the Healthcare System: Clinical Reflections on July 4th

Podcast: Deprescribing Insights From an ASCP Panel of Psychiatric Experts